Skip to main content

Cardiac Catheterization

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
suture mediated closureN/A1 trial
Active Trials
NCT00838175Unknown250Est. May 2009
Lantheus Medical Imaging
1 program
DefinityPHASE_21 trial
Active Trials
NCT03243942Completed56Est. Jun 2019
GE HealthCare
1 program
SonazoidPHASE_21 trial
Active Trials
NCT03245255Completed80Est. Jun 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GE HealthCareSonazoid
Lantheus Medical ImagingDefinity
Abbottsuture mediated closure

Clinical Trials (3)

Total enrollment: 386 patients across 3 trials

Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound

Start: Dec 2017Est. completion: Jun 202380 patients
Phase 2Completed

Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

Start: Jun 2017Est. completion: Jun 201956 patients
Phase 2Completed
NCT00838175Abbottsuture mediated closure

Characteristics Predictive of Success and Complications in the Use of Suture-Mediated Closure of Femoral Venous Access

Start: Jun 2007Est. completion: May 2009250 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.